| Primary |
| Computerised Tomogram |
20.4% |
| Angiogram Cerebral |
13.3% |
| Arteriogram Carotid |
11.0% |
| Carotid Artery Stent Insertion |
11.0% |
| Angiogram |
7.7% |
| Catheterisation Cardiac |
3.3% |
| Chest X-ray Abnormal |
3.3% |
| Joint Dislocation |
3.3% |
| Abdominal Mass |
2.8% |
| Abdominal Pain |
2.8% |
| Chest Pain |
2.8% |
| Hypertension |
2.8% |
| Angioplasty |
2.2% |
| Arteriogram |
2.2% |
| Dyspnoea |
2.2% |
| Peripheral Vascular Disorder |
2.2% |
| Aneurysm |
1.7% |
| Arthrogram |
1.7% |
| Nuclear Magnetic Resonance Imaging |
1.7% |
| Pain |
1.7% |
|
| Nephropathy Toxic |
22.3% |
| Anaphylactic Shock |
8.5% |
| Vomiting |
8.5% |
| Hypersensitivity |
6.4% |
| Loss Of Consciousness |
6.4% |
| Urticaria |
5.3% |
| Anaphylactic Reaction |
4.3% |
| Drug Administration Error |
4.3% |
| Nausea |
4.3% |
| Respiratory Depression |
4.3% |
| Arteriospasm Coronary |
3.2% |
| Dyspnoea |
3.2% |
| Injection Site Infection |
3.2% |
| Renal Failure |
3.2% |
| Bronchospasm |
2.1% |
| Cardiac Arrest |
2.1% |
| Cardio-respiratory Arrest |
2.1% |
| Cerebral Infarction |
2.1% |
| Cerebrovascular Accident |
2.1% |
| Extravasation |
2.1% |
|
| Secondary |
| Angiogram Cerebral |
11.3% |
| Computerised Tomogram |
10.3% |
| Abdominal Pain |
8.5% |
| Arteriogram Carotid |
8.5% |
| Carotid Artery Stent Insertion |
8.5% |
| Angiogram |
7.4% |
| Pain |
7.4% |
| Musculoskeletal Pain |
6.4% |
| Non-small Cell Lung Cancer |
4.3% |
| Hypertension |
3.5% |
| Dyspnoea |
3.2% |
| Arteriogram |
2.8% |
| Peripheral Vascular Disorder |
2.8% |
| Angioplasty |
2.1% |
| Chest Pain |
2.1% |
| Chest X-ray Abnormal |
2.1% |
| Constipation |
2.1% |
| Cough |
2.1% |
| Joint Dislocation |
2.1% |
| Lumbar Hernia |
2.1% |
|
| Nephropathy Toxic |
25.0% |
| Anaphylactic Shock |
10.0% |
| Drug Administration Error |
8.0% |
| Loss Of Consciousness |
6.0% |
| Anaphylactic Reaction |
5.0% |
| Vomiting |
5.0% |
| Cardiac Arrest |
4.0% |
| Multi-organ Failure |
4.0% |
| Respiratory Depression |
4.0% |
| Cerebrovascular Accident |
3.0% |
| Hypersensitivity |
3.0% |
| Injection Site Infection |
3.0% |
| Nausea |
3.0% |
| Renal Failure |
3.0% |
| Renal Failure Acute |
3.0% |
| Thrombocytopenia |
3.0% |
| Abasia |
2.0% |
| Bronchospasm |
2.0% |
| Cerebral Infarction |
2.0% |
| Dyspnoea |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.1% |
| Nuclear Magnetic Resonance Imaging |
18.4% |
| Angiogram |
8.2% |
| Computerised Tomogram |
6.7% |
| Coronary Artery Bypass |
4.6% |
| Fistulogram |
4.2% |
| Nuclear Magnetic Resonance Imaging Brain |
4.2% |
| Venogram |
3.5% |
| Catheterisation Cardiac |
3.4% |
| Computerised Tomogram Head |
3.2% |
| Hypertension |
1.2% |
| Aortic Valve Replacement |
1.1% |
| Pain |
1.1% |
| Prophylaxis Against Transplant Rejection |
1.1% |
| Premedication |
0.9% |
| Cardiac Stress Test |
0.5% |
| Echocardiogram |
0.5% |
| Computerised Tomogram Abdomen |
0.4% |
| Hypoparathyroidism |
0.4% |
| Mitral Valve Replacement |
0.4% |
|
| Injury |
9.3% |
| Discomfort |
7.9% |
| Dry Skin |
7.9% |
| General Physical Health Deterioration |
7.9% |
| Oedema Peripheral |
7.9% |
| Fear Of Death |
6.4% |
| Skin Tightness |
6.4% |
| Walking Aid User |
6.4% |
| Unevaluable Event |
5.7% |
| Anxiety |
4.3% |
| Fear |
4.3% |
| Renal Injury |
4.3% |
| Nephrogenic Fibrosing Dermopathy |
3.6% |
| Stress |
3.6% |
| Cerebral Infarction |
2.9% |
| Renal Failure |
2.9% |
| Anhedonia |
2.1% |
| Nephrogenic Systemic Fibrosis |
2.1% |
| Renal Failure Acute |
2.1% |
| Spinal Cord Infarction |
2.1% |
|